387 related articles for article (PubMed ID: 15460900)
21. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
[TBL] [Abstract][Full Text] [Related]
22. Replicative senescence in human uroepithelial cells.
Puthenveettil JA; Burger MS; Reznikoff CA
Adv Exp Med Biol; 1999; 462():83-91. PubMed ID: 10599415
[TBL] [Abstract][Full Text] [Related]
23. The lymphoma-associated NPM-ALK oncogene elicits a p16INK4a/pRb-dependent tumor-suppressive pathway.
Martinelli P; Bonetti P; Sironi C; Pruneri G; Fumagalli C; Raviele PR; Volorio S; Pileri S; Chiarle R; McDuff FK; Tusi BK; Turner SD; Inghirami G; Pelicci PG; Colombo E
Blood; 2011 Jun; 117(24):6617-26. PubMed ID: 21518927
[TBL] [Abstract][Full Text] [Related]
24. PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation.
Palanivel C; Madduri LSV; Hein AL; Jenkins CB; Graff BT; Camero AL; Zhou S; Enke CA; Ouellette MM; Yan Y
Aging (Albany NY); 2024 Mar; 16(5):4116-4137. PubMed ID: 38441530
[TBL] [Abstract][Full Text] [Related]
25. Contribution of the dual coding capacity of the p16INK4a/MTS1/CDKN2 locus to human malignancies.
Larsen CJ
Prog Cell Cycle Res; 1997; 3():109-24. PubMed ID: 9552410
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts.
Alcorta DA; Xiong Y; Phelps D; Hannon G; Beach D; Barrett JC
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13742-7. PubMed ID: 8943005
[TBL] [Abstract][Full Text] [Related]
27. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
Easton J; Wei T; Lahti JM; Kidd VJ
Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
[TBL] [Abstract][Full Text] [Related]
28. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
29. G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation.
Juan G; Ardelt B; Li X; Mikulski SM; Shogen K; Ardelt W; Mittelman A; Darzynkiewicz Z
Leukemia; 1998 Aug; 12(8):1241-8. PubMed ID: 9697879
[TBL] [Abstract][Full Text] [Related]
30. Cellular senescence and tumor suppressor gene p16.
Rayess H; Wang MB; Srivatsan ES
Int J Cancer; 2012 Apr; 130(8):1715-25. PubMed ID: 22025288
[TBL] [Abstract][Full Text] [Related]
31. The physiology of p16(INK4A)-mediated G1 proliferative arrest.
Shapiro GI; Edwards CD; Rollins BJ
Cell Biochem Biophys; 2000; 33(2):189-97. PubMed ID: 11325039
[TBL] [Abstract][Full Text] [Related]
32. p16 INK4a can initiate an autonomous senescence program.
Dai CY; Enders GH
Oncogene; 2000 Mar; 19(13):1613-22. PubMed ID: 10763818
[TBL] [Abstract][Full Text] [Related]
33. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
[TBL] [Abstract][Full Text] [Related]
34. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function.
Morris M; Hepburn P; Wynford-Thomas D
Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615
[TBL] [Abstract][Full Text] [Related]
35. Aging with ING: a comparative study of different forms of stress induced premature senescence.
Rajarajacholan UK; Riabowol K
Oncotarget; 2015 Oct; 6(33):34118-27. PubMed ID: 26439691
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
37. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
38. Parsing Ink4a/Arf: "pure" p16-null mice.
Sherr CJ
Cell; 2001 Sep; 106(5):531-4. PubMed ID: 11551500
[No Abstract] [Full Text] [Related]
39. Validation of signalling pathways: Case study of the p16-mediated pathway.
Akçay Nİ; Bashirov R; Tüzmen Ş
J Bioinform Comput Biol; 2015 Apr; 13(2):1550007. PubMed ID: 25582187
[TBL] [Abstract][Full Text] [Related]
40. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL
Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
